Pamela L. Kunz, MD (Medical Oncology)Associate Professor of Medicine/Oncology
Leader of the GI Cancers Program
Director of GI Medical Oncology
Yale New Haven/Yale Cancer Center
Smilow Cancer Hospital
New Haven, CT 06510
Dr. Kunz specializes in the treatment of gastrointestinal malignancies with an expertise in the care of patients with neuroendocrine tumors. She has developed broad investigative programs in the field of neuroendocrine tumors, encompassing clinical trials, population sciences, and translational correlates. She is the Principal Investigator on numerous Phase I, II and III clinical trials. She currently serves on the National Comprehensive Cancer Network (NCCN) Neuroendocrine Tumors Guidelines Panel, the NCI Neuroendocrine Tumor Taskforce, and the NANETS Guidelines and Executive Committees.
SPECIAL NOTE: Effective July 1, 2020, Dr. Kunz joins the faculty and staff at Yale, having served as Director of the Neuroendocrine Tumor Program at Stanford University in California. Additional contact information for Dr. Kunz will be added to this page shortly. Read more about Dr. Kunz’s appointment at Yale: https://medicine.yale.edu/news-article/22703/.